Standardization of PSA determinations

References

• Stamey T A, Yang N, Hay A R, McNeal J E, Freiha F S, Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987; 317: 909–16
   PubMed Web of Science ®Google Scholar
• Oesterling J E. Prostate specific antigen:a critical assessment of the most useful tumour marker for adenocarcinoma of the prostate. J Urol 1991; 145: 907–23
   PubMed Web of Science ®Google Scholar
• Catalona W J, Smith D S, Ratliff T L, Dodds K M, Coplen D E, Yuan J J, et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991; 324: 1156–61
   PubMed Web of Science ®Google Scholar
• Stamey T, Prestigiacomo A, Chen Z. Standardization of immunoassays for prostate specific antigen:a different view based on experimental observations. Cancer 1994; 74: 1662–6
   PubMed Web of Science ®Google Scholar
• Lundwall Å, Lilja H. Molecular cloning of human prostate specific antigen cDNA. FEBS Lett 1987; 214: 317–322
   PubMed Web of Science ®Google Scholar
• Watt K W, Lee P J, M'Timkulu T, Chan W P, Loor R. Human prostate-specific antigen: structural and functional similarity with serine proteases. Proc Natl Acad Sci USA 1986; 83: 3166–70
   PubMed Web of Science ®Google Scholar
• Schaller J, Akiyama K, Tsuda R, Hara M, Marti T, Rickli E. Isolation, characterization and amino acid sequence of γ-seminoprotein, a glycoprotein from human seminal plasma. Eur J Biochem 1987; 10–20; 1701
   Google Scholar
• Riegman P H, Vlietstra R J, Klaassen P, van der Korput J, Geuns van Kessel A, Romijn J C, Trapman J. The prostate-specific antigen gene and the human glandular kallikrein-1 gene are tandemly located on chromosome 19. FEBS Lett 1989; 247: 123–6
   PubMedGoogle Scholar
• Henttu P, Vihko P. cDNA coding for the entire prostate specific antigen shows high homologies to the human tissue kallikrein genes. Biochem Biophys Res Comm 1989; 160: 903–10
   PubMed Web of Science ®Google Scholar
• Lilja H. A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest 1985; 76: 1899–903
   PubMed Web of Science ®Google Scholar
• Christensson A, Laurell C B, Lilja H. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Biochem 1990; 194: 755–63
   PubMedGoogle Scholar
• Espana F, Sanchez C J, Vera C D, Estelles A, Gilabert J. A quantitative ELISA for the measurement of complexes of prostate-specific antigen with protein C inhibitor when using a purified standard. J Lab Clin Med 1993; 122: 711–9
   PubMedGoogle Scholar
• Stenman U H, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O. A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991; 51: 222–6
   PubMed Web of Science ®Google Scholar
• Leinonen J, Lovgren T, Vornanen T, Stenman U-H. Double-label time-resolved immunofluorometric assay of prostate-specific antigen and the complex between prostate-specific antigen with α1-antichymotrypsin. Clin Chem 1993; 39: 2098–103
   PubMed Web of Science ®Google Scholar
• Christensson A, Bjork T, Nilsson O, Dahlen U, Matikainen M T, Cockett A T, et al. Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer. J Urol 1993; 150: 100–5
   PubMed Web of Science ®Google Scholar
• Zhou A M, Tewari P C, Bluestein B I, Caldwell G W, Larsen F L. Multiple forms of prostate-specific antigen in serum: differences in immunorecognition by monoclonal and polyclonal assays. Clin Chem 1993; 39: 2483–91
   PubMed Web of Science ®Google Scholar
• Graves H C. Standardization of immunoassays for prostate-specific antigen. A problem of prostate-specific antigen complexation or a problem of assay design? Cancer 1993; 72: 3141–4
   Google Scholar
• Lilja H, Christensson A, Dahlen U, Matikainen M T, Nilsson O, Pettersson K, Lovgren T. Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. Clin Chem 1991; 37: 1618–25
   PubMed Web of Science ®Google Scholar
• Graves H C, Wehner N, Stamey T A. Comparison of a polyclonal and monoclonal immunoassay for PSA: need for an international antigen standard. J Urol 1990; 144: 1516–22
   PubMed Web of Science ®Google Scholar
• Vessella R L, Noteboom J, Lange P H. Evaluation of the Abbott IMx automated immunoassay of prostate-specific antigen. Clin Chem 1992; 38: 2044–54
   PubMedGoogle Scholar
• Stenman U-H, Bjorses U-M, Leinonen J. Time-resolved immunofluorometric assay of prostate-specific antigen. J Nucl Med Allied Sci 1990; 34: 249–51, Suppl. 3
   Google Scholar
• Brawer M K, Schifman R B, Ahmann F R, Ahmann M E, Coulis K M. The effect of digital rectal examination on serum levels of prostatic-specific antigen. Arch Pathol Lab Med 1988; 112: 1110–2
   PubMed Web of Science ®Google Scholar
• Chybowski F M, Bergstralh E J, Oesterling J E. The effect of digital rectal examination on the serum prostate specific antigen concentration: results of a randomized study. J Urol 1992; 148: 83–6
   PubMedGoogle Scholar
• Breul J, Binder K, Block T, Hartung R. Effect of digital rectal examination on serum concentration of prostate-specific antigen. Eur Urol 1992; 21: 195–9
   PubMedGoogle Scholar
• Simak R, Madersbacher S, Zhang Z F, Maier U. The impact of ejaculation on serum prostate specific antigen. J Urol 1993; 150: 895–7
   PubMed Web of Science ®Google Scholar
• Stenman U-H, Hakama M, Knekt P, Aromaa A, Teppo L, Leinonen J. Serum concentrations of prostate specific antigen and its complex with ai-antichymotrypsin before diagnosis of prostate cancer. Lancet 1994; 344: 1594–8
   PubMed Web of Science ®Google Scholar
• Sensabaugh G F, Blake E T. Seminal plasma protein p30: simplified purification and evidence for identity with prostate specific antigen. J Urol 1990; 144: 1523–6
   PubMed Web of Science ®Google Scholar
• Stenman U-H, Bidart J-M, Birken S, Mann K, Nisula B, O'Connor J. Standardization of protein immunoprocedures. Choriogonadotropin (CG). Scand J Clin Lab Invest 1993; 53: 42–78
   Web of Science ®Google Scholar
• Babaian R J, Miyashita H, Evans R B, Ramirez E L. The distribution of prostate specific antigen in men without clinical or pathological evidence of prostate cancer: relationship to gland volume and age. J Urol 1992; 147: 837–40
   PubMed Web of Science ®Google Scholar
• Oesterling J E, Jacobsen S J, Chute C G, Guess H A, Girman C J, Panser L A, Lieber M M. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA 1993; 270: 860–4
   PubMed Web of Science ®Google Scholar
• Littrup P, Kane R, Mettlin C, Murphy G, Lee F, Toi A, et al. Cost-effective prostate cancer detection. Cancer 1994; 74: 3146–58
   PubMed Web of Science ®Google Scholar